James Breitmeyer, Director at Zogenix, holds 1.25K shares in Zogenix (Ticker: ZGNX), holds ― shares in Otonomy (Ticker: OTIC), holds 655.74K shares in Oncternal Therapeutics (Ticker: ONCT).

See the Hottest Stocks Based on Insider Trading >

James Breitmeyer
Zogenix (ZGNX)
Director

Ranked #56,507 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

-7.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

ONCT

A breakdown of James Breitmeyer's holdings

See the Top Stocks by Insiders

Insider Roles

Oncternal Therapeutics
(ONCT)

CEO, Director

Roles that James Breitmeyer holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Oncternal Therapeutics
(ONCT)

Rating:Informative Buy

Date:Apr 17, 2023 - Apr 17, 2024

Return:+25.00%

The most profitable trade made by James Breitmeyer

See the Latest Stocks Traded by Insiders

James Breitmeyer's Trading History

ZGNX

Zogenix

Dec 18, 2019

―

Uninformative Sell

250.00K

$33.35K

OTIC

Otonomy

―

ONCT

Oncternal Therapeutics

Jan 05, 2024

CEO, Director

Uninformative Sell

27.17K

$5.41M

CADX

Cadence Pharma

―

List of latest transactions for each holding click on a transaction to see James Breitmeyer's performance on stock

See All Insider Trading from Today

James Breitmeyer insider profile FAQ

What is the percentage of profitable transactions made by James Breitmeyer?

The percentage of profitable transactions made by James Breitmeyer is 50%.

What is the average return per transaction made by James Breitmeyer?

The average return per transaction made by James Breitmeyer is -7.50%.

What stocks does James Breitmeyer hold?

James Breitmeyer holds: ZGNX, OTIC, ONCT, CADX stocks.

What was James Breitmeyer’s latest transaction?

James Breitmeyer latest transaction was an Uninformative Sell of $250.00K.

What was James Breitmeyer's most profitable transaction?

James Breitmeyer’s most profitable transaction was an Informative Buy of ONCT stock on April 17, 2023. The return on the trade was 25.00%.

What is James Breitmeyer's role in Zogenix?

James Breitmeyer's role in Zogenix is Director.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

James Breitmeyer Insider Profile

James Breitmeyer Zogenix (ZGNX)Director